Atlas Trials

First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer

Clinical trial NCT01437618 · COMPLETED

Trial details

NCT number
NCT01437618
Sponsor
Azienda Ospedaliero, Universitaria Pisana
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Colorectal Cancer
Start date
2009-06-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.